Scenario 1: A 47-Year-Old Man With Intermediate Risk Metastatic RCC

Expert perspectives on a patient scenario of intermediate risk metastatic renal cell carcinoma and corresponding management with combination immunotherapy.

Related Keywords

,Optimizing Outcomes ,Patients With ,Translating Evidence ,Clinical Practice ,Year Old Man With Intermediate Risk Metastatic ,Renal Cell Carcinoma ,Nrcc ,Kidney Cancer ,Metastatic Rcc ,Metastatic Kidney Cancer ,Advanced Rcc ,Advanced Kidney Cancer ,Nivolumab ,Ipilimumab ,Ipi Nivo ,Nivo Ipi ,Trio Therapy ,Immune Checkpoint Inhibitors ,Prednisone ,Liver Resection ,Left Radical Nephrectomy ,Consolidation Therapy ,Combination Therapy ,Novel Therapy ,